[
  {
    "criterion": "Provides accurate information about the dosage adjustment of aciclovir for patients with herpes zoster and renal impairment.",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Mentions the importance of monitoring the patient's renal function and hydration status.",
    "axis": "completeness",
    "point": 5
  },
  {
    "criterion": "Does not recommend increasing the dosage of aciclovir for patients with worsening renal function.",
    "axis": "accuracy",
    "point": 10
  },
  {
    "criterion": "Explains the impact of renal impairment on aciclovir excretion and the need for dose adjustment.",
    "axis": "context_awareness",
    "point": 8
  },
  {
    "criterion": "Provides a clear and concise explanation of the recommended dosage schedule.",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Does not recommend reducing the dosage of aciclovir to 800 mg once daily for patients with renal impairment.",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "Does not address the potential for increased risk of nephrotoxicity with aciclovir.",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Uses technical language that may be difficult for non-medical professionals to understand.",
    "axis": "communication_quality",
    "point": -2
  },
  {
    "criterion": "Does not provide guidance on the need for regular follow-up appointments to monitor the patient's response to treatment.",
    "axis": "completeness",
    "point": -5
  }
]